|
May 27
|
3 Mid-Cap Stocks Worth Your Attention
|
|
May 22
|
Natera to Present over 25 Signatera™ Studies at 2025 ASCO Annual Meeting
|
|
May 21
|
Exploring 3 High Growth Tech Stocks In The US Market
|
|
May 21
|
3 Stocks That May Be Trading Below Their Estimated Value
|
|
Apr 17
|
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
|
|
Apr 16
|
3 Top Stocks Estimated To Trade At Up To 48.4% Below Intrinsic Value
|
|
Apr 15
|
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers
|
|
Apr 14
|
High Growth Tech Stocks In US With Potential For Expansion
|
|
Apr 14
|
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)
|
|
Apr 12
|
Natera (NasdaqGS:NTRA) Climbs 11% in One Week
|
|
Apr 10
|
When Will Natera, Inc. (NASDAQ:NTRA) Turn A Profit?
|
|
Mar 14
|
Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value
|
|
Mar 14
|
Exploring Three High Growth Tech Stocks In The US Market
|
|
Mar 13
|
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board
|
|
Mar 11
|
Why Is Natera (NTRA) Stock Soaring Today
|
|
Mar 10
|
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
|
|
Feb 24
|
Natera, Inc. (NTRA): Among Top Stocks to Buy of Joe DiMenna’s Portfolio
|
|
Feb 19
|
Natera (NTRA) Surged on Blowout Quarterly Results
|
|
Feb 18
|
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
|
|
Feb 14
|
Schrodinger Stock Scores IBD Rating Upgrade
|